DoCTIS Combinatorial Therapies

Dr Sara Marsal
sara.marsal@vhir.org

Request Access

Dataset ID	Description	Technology	Samples
EGAD50000001964	Single-cell RNA-Seq data of patients representing 6 different IMIDs and healthy controls from the DoCTIS project	Illumina NovaSeq 6000	386
EGAD50000002832	A total of 48 samples from RA donors were profiled with scRNA-Seq. Samples were collected 12 weeks after therapy. Three different therapies were considered: antiTNF, antiIL6R, and JAKi.	Illumina NovaSeq 6000	94
EGAD50000002833	Transcriptome characterization with scRNA-Seq of macrophages derived from HLA-DRB1 negative and HLA-DRB1 positive monocytes cultivated in vitro	Illumina NovaSeq 6000	2
EGAD50000002834	Longitudinal transcriptomic data from 380 blood samples across six IMIDs treated with multiple targeted therapies.	Illumina NovaSeq 6000	352
EGAD50000002840	A validation cohort with 32 samples from RA donors were profiled with scRNA-Seq	Illumina NovaSeq 6000	64